Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Hypercoagulability: another potential mechanism of obstructive sleep apnea-related cardiovascular disease?

× No keyword cloud information.

25 in total

Review 1. Plasminogen-activator inhibitor type 1 and coronary artery disease.

Authors: H P Kohler; P J Grant
Journal: N Engl J Med Date: 2000-06-15 Impact factor: 91.245

2. Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up.

Authors: Yüksel Peker; Jan Hedner; Jeanette Norum; Holger Kraiczi; Jan Carlson
Journal: Am J Respir Crit Care Med Date: 2002-07-15 Impact factor: 21.405

3. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies.

Authors: J Danesh; R Collins; P Appleby; R Peto
Journal: JAMA Date: 1998-05-13 Impact factor: 56.272

4. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study.

Authors: E Shahar; C W Whitney; S Redline; E T Lee; A B Newman; F J Nieto; G T O'Connor; L L Boland; J E Schwartz; J M Samet
Journal: Am J Respir Crit Care Med Date: 2001-01 Impact factor: 21.405

5. Morning increase of whole blood viscosity in obstructive sleep apnea syndrome.

Authors: L Nobili; G Schiavi; E Bozano; F De Carli; F Ferrillo; F Nobili
Journal: Clin Hemorheol Microcirc Date: 2000 Impact factor: 2.375

6. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study.

Authors: Jose M Marin; Santiago J Carrizo; Eugenio Vicente; Alvar G N Agusti
Journal: Lancet Date: 2005 Mar 19-25 Impact factor: 79.321

Hypercoagulability: another potential mechanism of obstructive sleep apnea-related cardiovascular disease?

Review 1. Plasminogen-activator inhibitor type 1 and coronary artery disease.

2. Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up.

3. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies.

4. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study.

5. Morning increase of whole blood viscosity in obstructive sleep apnea syndrome.

6. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study.

7. Platelet function and fibrinolytic activity in hypertensive and normotensive sleep apnea patients.

8. The occurrence of sleep-disordered breathing among middle-aged adults.

9. Hematocrit levels in sleep apnea.

10. Plasminogen activator inhibitor-1 in obstructive sleep apnea patients with and without hypertension.

Review 1. Obstructive Sleep Apnea as a Risk Factor for Venous Thromboembolism: A Systematic Review.